Vimarsana
Biggest News Aggregation in the World

Harold Bernstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harold Bernstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harold Bernstein Today - Breaking & Trending Today

CNNW CNN Newsroom Live August 27, 2016 - Vimarsana News

CNNW CNN Newsroom Live August 27, 2016

World. Im George Howell. Cnn newsroom starts right now. 4 00 a a. M. On the u. S. East coast. In just about 90 minutes time in italy, a state funeral is set to begin for some of the victims of wednesdays powerful earthquake in the central part of that nation. Youre looking at live images this hour. It is 10 01 there where you see the service is about to start. 281 people were killed. Rescuers there are hoping to find more survivors trapped in the rubble. But as each day passes, that hope is fading fast. In the meantime, thousands of people are living in camps until the Civil Protection agency ...

FOXNEWSW Shepard Smith Reporting May 1, 2018 - Vimarsana News

FOXNEWSW Shepard Smith Reporting May 1, 2018

Affect the thinking about the Iran Nuclear Deal . Certainly the fact that the deal was made under false pretenses is problematic. But the president has been clear he thinks that the deal is one of the worst we have seen. We will keep you posted when he made a final decision on the front. When did the president first hear about this. Was it in early march when he spoke to the Prime Minister Benjamin Netanyahu . Im not aware of the exact date that the president was made aware but the white house and the president were made aware prior to israel announcement yesterday. Was this coordinated yester...

Maze Therapeutics Highlights New Preclinical Data Supporting Advancement of APOL1 Inhibitor Candidat - Vimarsana News

Maze Therapeutics Highlights New Preclinical Data Supporting Advancement of APOL1 Inhibitor Candidat

Data Presented During ASN Kidney Week 2023 Demonstrate Significant Reversal of Albuminuria in Chronic Disease ModelFirst-in-Human Trial of MZE829 Development Candidate Anticipated to Begin by End of 2023SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Maze Therapeutics, a company translating genetic insights into new p...

Sanofi Finds Way to Maze Therapeutics to Get Its Next Pompe Disease Drug - Vimarsana News

Sanofi Finds Way to Maze Therapeutics to Get Its Next Pompe Disease Drug

Sanofi is acquiring rights to a Maze Therapeutics drug candidate for Pompe disease that could give the pharmaceutical giant another option to offer patients who have the rare metabolic disorder. In February, the drug posted positive data from a Phase 1 study.

Sanofi strikes a $150M deal for Maze's Pompe disease drug - Vimarsana News

Sanofi strikes a $150M deal for Maze's Pompe disease drug

BioPharma